Shares below Rs 100: Only buyers were seen in these stocks on December 21!
Shares below Rs 100: Only buyers were seen in these stocks on December 21!

Shares below Rs 100: Only buyers were seen in these stocks on December 21!

BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.

Mandar Wagh Article rating: 4.1

BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.  

This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'
This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

Shares of the company zoomed on getting CEP approval to manufacture Ibuprofen from the Vishakhapatnam facility.

Tushar Jain Article rating: 4.0

Solara Active Pharma Sciences (Solara) has received ‘Certificate of Suitability (CEP) approval for its new state-of-the-art multipurpose API manufacturing facility at Vishakhapatnam.

Stocks below Rs 100: Only buyers seen in these scrips on February 17
Stocks below Rs 100: Only buyers seen in these scrips on February 17

Stocks below Rs 100: Only buyers seen in these scrips on February 17

At 3.30 pm on Thursday, the core equity indices i.e., Sensex and Nifty 50 saw a correction similar to the last trading session.

Sayali Kotwal Article rating: 4.0

At 3.30 pm on Thursday, the core equity indices i.e., Sensex and Nifty 50 saw a correction similar to the last trading session. The Sensex was at 57,824, down by 172.68 points or 0.30 per cent, while Nifty was at 17,283.80 down by 38.40 points or 0.22 per cent from the last trading session.   

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR